These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33256573)

  • 1. Outcomes of endovascular treatment for infrapopliteal peripheral artery disease based on the updated TASC II classification.
    Müller AM; Räpple V; Bradaric C; Koppara T; Kehl V; Fusaro M; Cassese S; Ott I; Kastrati A; Laugwitz KL; Ibrahim T
    Vasc Med; 2021 Feb; 26(1):18-25. PubMed ID: 33256573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midterm Outcomes After Infrapopliteal Interventions in Patients With Critical Limb Ischemia Based on the TASC II Classification of Below-the-Knee Arteries.
    Singh GD; Brinza EK; Hildebrand J; Waldo SW; Foley TR; Laird JR; Armstrong EJ
    J Endovasc Ther; 2017 Jun; 24(3):321-330. PubMed ID: 28421855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery.
    Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
    JACC Cardiovasc Interv; 2014 Jul; 7(7):792-8. PubMed ID: 25060024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular Treatment for Steno-Occlusive Iliac Artery Disease: Safety and Long-Term Outcome.
    Müller AM; Langwieser N; Bradaric C; Haller B; Fusaro M; Ott I; von Beckerath N; Kastrati A; Laugwitz KL; Ibrahim T
    Angiology; 2018 Apr; 69(4):308-315. PubMed ID: 28747061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mid-Term Outcomes of Endovascular Treatment for TASC-II D Femoropopliteal Occlusive Disease with Critical Limb Ischemia.
    Torres-Blanco Á; Edo-Fleta G; Gómez-Palonés F; Molina-Nácher V; Ortiz-Monzón E
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):344-52. PubMed ID: 26202389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes for systematic primary stent placement in complex iliac artery occlusive disease classified according to Trans-Atlantic Inter-Society Consensus (TASC)-II.
    Ichihashi S; Higashiura W; Itoh H; Sakaguchi S; Nishimine K; Kichikawa K
    J Vasc Surg; 2011 Apr; 53(4):992-9. PubMed ID: 21215582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Antegrade Approach Using Transbrachial Access Improves Technical Success Rate of Endovascular Recanalization of TASC C-D Aortoiliac Occlusion in Case of Failed Femoral Access.
    Millon A; Della Schiava N; Brizzi V; Arsicot M; Boudjelit T; Herail J; Feugier P; Lermusiaux P
    Ann Vasc Surg; 2015 Oct; 29(7):1346-52. PubMed ID: 26122414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
    Ascher E; Marks NA; Hingorani AP; Schutzer RW; Mutyala M
    J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of endovascular interventions for TASC II B and C femoropopliteal lesions.
    Baril DT; Marone LK; Kim J; Go MR; Chaer RA; Rhee RY
    J Vasc Surg; 2008 Sep; 48(3):627-33. PubMed ID: 18727966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of statin therapy with the primary patency of femoral and popliteal artery stents.
    de Grijs D; Teixeira P; Katz S
    J Vasc Surg; 2018 May; 67(5):1472-1479. PubMed ID: 29224939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of endovascular treatment of TASC-II C and D femoropopliteal lesions with the Viabahn endoprosthesis.
    Mohr PJ; Oyama JK; Luu JT; Stinis CT
    Cardiovasc Revasc Med; 2015 Dec; 16(8):465-8. PubMed ID: 26483319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iliac artery stenting combined with open femoral endarterectomy is as effective as open surgical reconstruction for severe iliac and common femoral occlusive disease.
    Piazza M; Ricotta JJ; Bower TC; Kalra M; Duncan AA; Cha S; Gloviczki P
    J Vasc Surg; 2011 Aug; 54(2):402-11. PubMed ID: 21531527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year clinical outcome after primary stenting for Trans-Atlantic Inter-Society Consensus (TASC) C and D femoropopliteal lesions (the STELLA "STEnting Long de L'Artère fémorale superficielle" cohort).
    Davaine JM; Azéma L; Guyomarch B; Chaillou P; Costargent A; Patra P; Lambert G; Gouëffic Y
    Eur J Vasc Endovasc Surg; 2012 Oct; 44(4):432-41. PubMed ID: 22920949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: A supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): The TASC steering committee.
    Jaff MR; White CJ; Hiatt WR; Fowkes GR; Dormandy J; Razavi M; Reekers J; Norgren L
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):611-25. PubMed ID: 26256456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Total Aortoiliac Revascularization for TASC-II C&D Lesion with Kissing Self-Expanding Covered Stents.
    Shen C; Zhang Y; Qu C; Fang J; Liu X; Teng L
    Ann Vasc Surg; 2020 Oct; 68():434-441. PubMed ID: 32422290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
    Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
    J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of endovascular treatment for TASC C and D aorto-iliac lesions.
    Ahn S; Park KM; Kim YK; Kim JI; Moon IS; Hong KC; Jeon YS; Kim JY
    Asian J Surg; 2017 May; 40(3):215-220. PubMed ID: 26787498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endovascular interventions for TransAtlantic InterSociety Consensus II C and D femoropopliteal lesions.
    Yin MY; Jiang ME; Huang XT; Lu M; Lu XW; Huang Y; Li WM
    Chin Med J (Engl); 2013 Feb; 126(3):415-20. PubMed ID: 23422099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic outcome of endovascular therapy for TransAtlantic InterSociety Consensus type B femoropopliteal arterial occlusive lesions.
    Costanza MJ; Queral LA; Lilly MP; Finn WR
    J Vasc Surg; 2004 Feb; 39(2):343-50. PubMed ID: 14743134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.